ARTICLE | Company News
Eisai sales and marketing update
September 17, 2012 7:00 AM UTC
Eisai launched Fycompa perampanel in the U.K. as an adjunctive therapy for partial-onset seizures in epilepsy patients 12 years and older with or without secondarily generalized seizures. The NHS lis...